TSHA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Taysha Gene Therapies Inc

Watchlist Manager

Watchlist

Price: 4.37 USD 0.92% Market Closed

Market Cap: $1.4B

Profitability Summary

Taysha Gene Therapies Inc's profitability score is . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2 855%

Negative 3Y Average Operating Margin

-1 208%

Declining Operating Margin

-517% > -2 855%

Negative Net Margin

-2 728%

Negative 3Y Average Net Margin

-1 205%

Declining Net Margin

-1 497% > -2 728%

Negative Free Cash Flow Margin

-2 417%

Negative 3Y Average Free Cash Flow Margin

-1 072%

Declining Free Cash Flow Margin

-337% > -2 417%

Negative ROE

-47%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-598%

Declining ROIC

-173% > -1 673%

View All Checks

Profitability Score

Margins, capital efficiency and cash flow, summed up in one score.

Create a free account · No card needed

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.